Table 4 Agreement of each method in the hypoglycemic range
First author (year) | Devices | Methods | Definition (mg/dl) | No of samples | Non Agreement proportion < 5% | Non agreement proportion | Over estimation | Under estimation | Non agreement in non-hypo range | Odds ratio (95% CI) | Ref |
|---|---|---|---|---|---|---|---|---|---|---|---|
ABG | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Corstjens AM (2006) | ABL 715 | Zone A | 70 | 22 | No | 13/22 (59%) | 13/22 (59%) | 0/22 (0) | 165/394 (41.9%) | 2.00 (0.84, 4.80) | [16] |
Kanji S (2005) | RapidLab 860 | Within 20% | 81 | 37 | Yes | 0/37 (0) | 0/37 (0) | 0/37 (0) | 1/78 (1.3%) | 0.69 (0.03, 17.3) | [19] |
Total | Â | Â | Â | 59 | 1/2 (50%) | 13/59 (22.0%) | 13/59 (22.0%) | 0/59 (0) | 166/472 (35.2%) | 1.86 (0.80, 4.33) | Â |
Gluco-C | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Kanji S (2005) | Accu-Chek Inform | Within 20% | 81 | 38 | No | 14/38 (38%) | 11/38 (30%) | 3/38 (8%) | 18/80 (22.5%) | 2.30 (1.00, 5.32) | [19] |
Lonjaret L (2012) | Contour | Within 20% | 81 | 25 | No | 8/25 (32%) | 3/25 (12%) | 5/25 (20%) | 67/277 (24.2%) | 1.47 (0.61, 3.57) | [23] |
Critchell CD (2007) | Accu-Chek Inform | < 15 mg/dl | 75 | 14 | No | 4/14 (29%) | 1/14 (7%) | 3/14 (21%) | 49/263 (18.6%) | 1.75 (0.53, 5.80) | [24] |
Total | Â | Â | Â | 77 | 0/3 (0%) | 26/77 (33.8%) | 15/77 (19.5%) | 11/77 (14.3%) | 134/620 (21.6%) | 1.84 (1.07,3.16) | Â |
Gluco-A | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Kanji S (2005) | Accu-Chek Inform | Within 20% | 81 | 36 | No | 8/36 (22%) | 6/36 (17%) | 2/36 (6%) | 6/77 (7.8%) | 3.38 (1.08, 10.6) | [19] |
Lonjaret L (2012) | Contour | Within 20% | 81 | 25 | No | 5/25 (20%) | 1/25 (4%) | 4/25 (16%) | 30/277 (10.8%) | 2.06 (0.72, 5.89) | [23] |
Meynaar IA (2009) | Accu-Check Inform | < 15 mg/dl | 75 | 10 | No | 1/10 (10%) | 1/10 (10%) | 0/10 (0%) | 21/229 (9.2%) | 1.10 (0.13, 9.12) | [25] |
Total | Â | Â | Â | 71 | 0/3 (0%) | 14/71 (19.7%) | 8/71 (11.3%) | 6/71 (8.4%) | 57/583 (9.8%) | 2.33 (1.13, 4.83) | Â |